Healthy Term Infants
2
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AbbottABBOTT PARK, IL
2 programs2
Hydrolysate based infant formulaPhase 31 trial
Milk based infant formula powderPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbbottMilk based infant formula powder
AbbottHydrolysate based infant formula
Johnson & JohnsonInfant formula
Clinical Trials (3)
Total enrollment: 966 patients across 3 trials
Growth and Tolerance of Healthy Term Infants to a New Infant Formula
Start: May 2010Est. completion: Oct 2010399 patients
Phase 3Terminated
Tolerance of Healthy Term Infants Fed Infant Formulas #4
Start: Mar 2010Est. completion: Jul 2010168 patients
Phase 3Completed
The Evaluation of Cow's Milk Formula - Study B
Start: Aug 2008Est. completion: Oct 2009399 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.